Patents-Review.com
🔗 Permalink
Assignee profile:

Albireo AB

City:

Goteborg

Country:

Sweden

Published Applications:

13

Last publication date:

2021-06-10

Patent Grants:

11

Last grant date:

2021-05-25

Top Inventors for applications by Albireo AB

These are the the leading inventors for applications assigned to Albireo AB:

Recent patent applications by Albireo AB

Albireo AB based in Goteborg, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-06-10 ✅ Patent 11,014,898 granted on 2021-05-25
US20210171479A1
Chemistry; metallurgy

Benzothiazepine compounds and their use as bile acid modulators

 #2 | 2020-05-07 ✅ Patent 10,981,952 granted on 2021-04-20
US20200140484A1
Chemistry; metallurgy

IBAT inhibitors for the treatment of liver diseases

 #3 | 2020-02-13 ✅ Patent 10,722,457 granted on 2020-07-28
US20200046636A1
Human necessities

Oral cholestyramine formulation and use thereof

 #4 | 2018-12-20 ✅ Patent 10,221,212 granted on 2019-03-05
US20180362577A1
Chemistry; metallurgy

IBAT inhibitors for the treatment of liver diseases

 #5 | 2018-12-20 ✅ Patent 10,493,096 granted on 2019-12-03
US20180360870A1
Human necessities

Oral cholestyramine formulation and use thereof

 #6 | 2018-09-20 ✅ Patent 10,610,543 granted on 2020-04-07
US20180264030A1
Human necessities

Cholestyramine pellets and methods for preparation thereof

 #7 | 2018-06-14 ✅ Patent 10,487,111 granted on 2019-11-26
US20180162904A1
Chemistry; metallurgy

IBAT inhibitors for the treatment of liver diseases

 #8 | 2017-08-10 ✅ Patent 10,441,605 granted on 2019-10-15
US20170224721A1
Human necessities

Oral cholestyramine formulation and use thereof

 #9 | 2017-08-10 ✅ Patent 10,441,604 granted on 2019-10-15
US20170224719A1
Human necessities

Cholestyramine pellets and methods for preparation thereof

 #10 | 2017-06-29 ✅ Patent 9,694,018 granted on 2017-07-04
US20170182059A1
Human necessities

IBAT inhibitors for the treatment of liver disease

 #11 | 2016-07-07 ✅ Patent 9,688,720 granted on 2017-06-27
US20160193277A1
Human necessities

IBAT inhibitors for the treatment of liver diseases

 #12 | 2013-09-12
US20130236541A1
Human necessities

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

 #13 | 2012-05-10
US20120114588A1
Chemistry; metallurgy

IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS

Also check out Albireo AB's (Göteborg, Sweden) applicant profile with 16 patent applications submitted.

AssigneeID:

38531 ⎘